• 

  April 29, 2026

  OHSU Secures $9.2M NIH Grant to Advance Bone Cancer Organs-on-Chips Research

  R.D. Solorzano

• 

  April 27, 2026

  The Organ-on-Chip, Microphysiological Systems Landscape, NAMs: A Business Overview

  R.D. Solorzano

• 

  April 24, 2026

  Linton Lifesciences Launches Biofabricated NAMs: Rebuilding the Missing Layer Between Biology and Decision-Making

  R.D. Solorzano

• 

  April 6, 2026

  NAMs, New Approach Methodologies for Drug Discovery: What It Means for the Future of Alternatives to Animal Testing and Biofabrication

  R.D. Solorzano

• 

  December 15, 2025

  Revalia Bio Secures ~$30M Government Contract to Build the Future of Human-First Drug Development

  R.D. Solorzano

• 

  October 10, 2025

  JETT: Connecting Innovators with the Joint Chem Bio Enterprise

  R.D. Solorzano

• 

  October 3, 2025

  NIH Launches Nation’s First Dedicated Organoid Development Center

  R.D. Solorzano

• 

  September 25, 2025

  MIT and Polimi Develop Low-Cost AI Monitoring System to Improve 3D Bioprinting of Engineered Tissues

  R.D. Solorzano

• 

  August 8, 2025

  Instant Collagen, Real-Time Biofabrication: What TRACE Means for the Lab & the Market

  R.D. Solorzano

• 

  July 16, 2025

  CollPlant Expands U.S. Footprint with Strategic Hire to Lead Commercial GrowthBusiness of Biofabrication

  R.D. Solorzano